Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 15.06.2026 1 AJR Am J Roentgenol 6 Am J Gastroenterol 1 Am J Pathol 1 Biochem Biophys Res Commun 2 BMC Cancer 3 BMC Gastroenterol 1 Cancer 1 Clin Res Hepatol Gastroenterol 1 Eur Radiol 1 Gastrointest Endosc 2 Gut 4 Hepatology 1 Int J Cancer 1 J Gastroenterol Hepatol 1 J Hepatol 1 J Pediatr Surg 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiology 2 Transplant Proc 2 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. KIM J, Lee EJ, Yoon H, Han K, et al
   Associations of Ultrasound-Derived Fat Fraction and MRI PDFF Measurements: A Prospective Study in Pediatric Patients With Suspected MASLD.
   AJR Am J Roentgenol. 2026 Jan 21. doi: 10.2214/AJR.25.34230.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. PEREZ-VALENZUELA J, Prospert O, Alvarez-Lobos M, Vargas JI, et al
   A Moving Target: EUS Diagnosis of Live Fasciola hepatica Mimicking Distal Cholangiocarcinoma.
   Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004078.
   PubMed        
   
   
3. KIM SH, Deutsch-Link S, Buttenheim AM, Starbird LE, et al
   Barriers and Facilitators of Alcohol Use Disorder Treatment for Alcohol-Associated Liver Disease: A Systematic Review.
   Am J Gastroenterol. 2026;121:1312-1325.
   PubMed         Abstract available
   
   
4. SANDAHL TD, Harrington CF, Kirk FT, Carpenter G, et al
   Diagnosing Wilson Disease in Acute Liver Failure: Comparison of Existing and Experimental Biomarkers.
   Am J Gastroenterol. 2026;121:1393-1400.
   PubMed         Abstract available
   
   
5. VAN KLEEF LA, Michel M, Savas M, Pustjens J, et al
   A Comparison of the Predictive Value of 12 Body Composition Markers for Metabolic Dysfunction-Associated Steatotic Liver Disease, At-Risk Metabolic Dysfunction-Associated Steatohepatitis, and Increased Liver Stiffness in a General Population Setting.
   Am J Gastroenterol. 2026;121:1382-1392.
   PubMed         Abstract available
   
   
6. JUNTING L, Jiaqi Z, Chenye L, Shiwei Y, et al
   The Wandering Liver and Gallbladder: Right Massive Hepatodiaphragmatic Hernia.
   Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004079.
   PubMed        
   
   
7. ORMAN ES, Johnson AW, Rockey DC, Serper M, et al
   Caregiver Involvement and Burden and Patient Quality of Life in Patients with Decompensated Cirrhosis.
   Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004076.
   PubMed         Abstract available
   
   

   
   Am J Pathol

8. VAYRYNEN VJ, Eloranta K, Talka M, Tuhkala A, et al
   Macrophage polarization and spatial architecture characterize the tumor immune microenvironment and prognosis in hepatoblastoma.
   Am J Pathol. 2026 Jun 10:S0002-9440(26)00164.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

9. GUAN W, Lv Z, Peng H, Gao H, et al
   Activated B lymphocytes induce hepatocyte injury in autologous co-culture system.
   Biochem Biophys Res Commun. 2026;828:154087.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LU H, Liang B, Zheng C, Cao Y, et al
    Efficacy and safety analysis of TACE combined with lenvatinib and icaritin in unresectable hepatocellular carcinoma with poor performance status.
    BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16322.
    PubMed         Abstract available
    
    
11. TANG S, Cai H, Wu Z, Huang S, et al
    An integrated pathway mutation and clinical model predicts survival in unresectable HCC with hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab.
    BMC Cancer. 2026 Jun 6. doi: 10.1186/s12885-026-16286.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

12. PAN Y, Song F, Liu X, Zhang Y, et al
    Dual GIP/GLP-1 receptor agonist tirzepatide ameliorates hepatic steatosis and inflammatory responses in a MASLD mouse model associated with the CCL2/CCR2 axis.
    BMC Gastroenterol. 2026 Jun 5. doi: 10.1186/s12876-026-04986.
    PubMed         Abstract available
    
    
13. ZHAO H, Li T, Zhang Y, Song Y, et al
    TACE, lenvatinib, and PD-1 inhibitors in unresectable advanced hepatocellular carcinoma: an exploratory retrospective cohort study.
    BMC Gastroenterol. 2026 Jun 10. doi: 10.1186/s12876-026-04985.
    PubMed         Abstract available
    
    
14. HEGAZY MA, Mohamed SS, Saad EH, Abdelghani A, et al
    Selenoprotein P deficiency in MASLD: association with insulin resistance and liver fibrosis: a prospective case-control study.
    BMC Gastroenterol. 2026;26:340.
    PubMed         Abstract available
    
    

    
    Cancer

15. 
    Correction to "Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis".
    Cancer. 2026;132:e70456.
    PubMed        
    
    

    
    Clin Res Hepatol Gastroenterol

16. EVLENDI Y, Eldem G, Sarikaya SA, Yalcin S, et al
    Chemotherapy as a salvage strategy after immunotherapy failure in advanced hepatocellular carcinoma: A case series.
    Clin Res Hepatol Gastroenterol. 2026;50:102831.
    PubMed         Abstract available
    
    

    
    Eur Radiol

17. CANNELLA R, Vernuccio F, Reiner CS, De Paepe KN, et al
    Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging Forum.
    Eur Radiol. 2026 Jun 9. doi: 10.1007/s00330-026-12567.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

18. YANNI G, El Khoury M, Nehme F
    Pancreatic Duct Stone Formation Secondary to Migrated Surgical Staple Following Roux-en-Y Hepaticojejunostomy.
    Gastrointest Endosc. 2026 Jun 8:S0016-5107(26)06806.
    PubMed        
    
    

    
    Gut

19. WONG F, Adebayo D, George J, Idilman R, et al
    Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective.
    Gut. 2026 Jun 5:gutjnl-2025-336802. doi: 10.1136/gutjnl-2025-336802.
    PubMed         Abstract available
    
    
20. LEE CH, Bui TPN, Petitfils C, Jian C, et al
    Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.
    Gut. 2026;75:1338-1352.
    PubMed         Abstract available
    
    

    
    Hepatology

21. LIM AS, Cruz SN, Uddin AA, Malysheva O, et al
    Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferase.
    Hepatology. 2026;83:1515-1528.
    PubMed         Abstract available
    
    
22. BAKITAS M, Hoppmann N, Stockdill M, Gazaway S, et al
    Developing palliative care interventions in liver disease using formative and summative qualitative evaluation.
    Hepatology. 2026;83:1557-1576.
    PubMed         Abstract available
    
    
23. HUI VW, Tang JC, Wong VW, Liang LY, et al
    HBsAg seroclearance further reduces hepatocellular carcinoma but not hepatic decompensation in patients with cirrhosis and complete viral suppression.
    Hepatology. 2026 Jun 8. doi: 10.1097/HEP.0000000000001804.
    PubMed         Abstract available
    
    
24. LIN K, Zhang N, Zhang Z, Zhou X, et al
    High resolution spatial transcriptomics identifies insufficient radiofrequency ablation induces hepatocellular carcinoma progression via CEBPD / CXCL2 axis.
    Hepatology. 2026 Jun 8. doi: 10.1097/HEP.0000000000001714.
    PubMed         Abstract available
    
    

    
    Int J Cancer

25. ZHANG D, Xie Q, Zhang Z, Wang S, et al
    Real-World Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study.
    Int J Cancer. 2026 Jun 11. doi: 10.1002/ijc.70590.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

26. HE WZ, Lao JQ, Luo WW, Ye PH, et al
    Adjuvant Immunotherapy for Hepatocellular Carcinoma: The Need for Broader Evidence.
    J Gastroenterol Hepatol. 2026 Jun 7. doi: 10.1111/jgh.70494.
    PubMed        
    
    

    
    J Hepatol

27. HAMANN V, Hook S, Sujariyakul P, Ramalingam R, et al
    In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.
    J Hepatol. 2026 Jun 10:S0168-8278(26)02625-5. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

28. UCHIDA H, Sakamoto S, Ohshiro A, Kojima M, et al
    Limitations of adult post-hepatectomy liver failure criteria in pediatric liver tumor surgery: A single-center retrospective study.
    J Pediatr Surg. 2026;61:163045.
    PubMed         Abstract available
    
    

    
    PLoS One

29. WEI C, Cao C, Xu Z, Chen G, et al
    Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study.
    PLoS One. 2026;21:e0350633.
    PubMed         Abstract available
    
    
30. RAMEZANI R, Rabiei MR, Arashi M
    Integrating preliminary test and Stein-type techniques to improve estimation in the time-dependent Cox model.
    PLoS One. 2026;21:e0345123.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. KLUIVER TA, Nordin A, Lu Y, Guo X, et al
    Differential Wnt/beta-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes.
    Proc Natl Acad Sci U S A. 2026;123:e2528450123.
    PubMed         Abstract available
    
    

    
    Radiology

32. HEO S, Jung YJ, Choi ES, Kim S, et al
    Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.
    Radiology. 2026;319:e253854.
    PubMed         Abstract available
    
    

    
    Transplant Proc

33. HUA Y, Wang Z, Wang M, Li Y, et al
    Mitochondrial Transplantation-Mediated Restoration of Mitochondrial Function Alleviates Hepatic Ischemia-Reperfusion Injury in Mice.
    Transplant Proc. 2026 Jun 10:S0041-1345(26)00280.
    PubMed         Abstract available
    
    
34. FERNANDEZ PP, Rodriguez DYG, Torres LIR, Gomez JCV, et al
    The Weight of Balance: Anesthetic Management in Liver Transplantation for Critically Ill Patients. A Case Report.
    Transplant Proc. 2026 Apr 20:S0041-1345(26)00161.
    PubMed         Abstract available
    
    

    
    Transplantation

35. KORATALA A, Kazory A
    Hepato-Cardio-Renal Interactions and Transplant Implications.
    Transplantation. 2026 Jun 9. doi: 10.1097/TP.0000000000005794.
    PubMed         Abstract available
    
    
36. YAMABE S, Kuse Y, Okumura T, Kasai T, et al
    Oxygenated Perfusion Enhances Hepatocyte Function in Human iPSC-liver Tissue.
    Transplantation. 2026 Jun 10. doi: 10.1097/TP.0000000000005684.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum